Office Of New Drugs' Kweder Will Represent FDA At Vioxx Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Office of New Drugs Acting Director Sandra Kweder. MD, will represent FDA at the Senate Finance Committee hearing on the Vioxx withdrawal Nov. 18